The MDMA Therapy Training Program has launched a series of trainings to prepare therapy providers to become eligible to work on an MDMA-assisted psychotherapy for PTSD protocol.
The last MDMA Therapy Training retreat for 2019 was held October 1-8, 2019. Forty-nine trainees gathered in Asheville, North Carolina, to receive training from Annie Mithoefer, B.S.N., and Michael Mithoefer, M.D. The MDMA Therapy Trainers gathered in November for a Trainers Retreat to reflect on the 2019 year and strategize about the year ahead and the future of the MDMA Therapy Training Program. There are no dates scheduled for 2020 trainings yet. The training team will be planning dates and tuition fees for the 2020 training year and announcing that information through the MDMA Therapy Training Newsletter in the months to come. Please sign up for the Training Program Newsletter to receive these updates.
Sites in the U.S. and U.S. territories interested in being considered to participate in an Expanded Access MDMA/PTSD protocol may now apply with MAPS Public Benefit Corporation (MAPS PBC) to assess eligibility and obtain the prerequisite training to administer MDMA-assisted psychotherapy. The basic requirements of a qualified site are 1) treatment facility conducive to MDMA-assisted psychotherapy, 2) therapy team, qualified and able to complete MDMA Therapy Training Program, and 3) prescribing physician who can obtain a DEA Schedule I license for MDMA.
Additional site and practitioner requirements are posted on the MAPS PBC website. Each site must submit one site questionnaire and all applicants interested in training need to complete a therapy training application for providers. Only applicants affiliated with a qualifying site can be considered for training at this time. MAPS PBC will review applications on an ongoing basis, as they are received. The MAPS PBC Therapy Provider Connect Portal is a community discussion forum for therapy providers, physicians and facilities to connect with one another to develop a site or treatment staff, in order to become eligible to participate in a MAPS PBC Expanded Access MDMA/PTSD protocol.